Tomasz Franciszek Baran

Corporate Officer/Principal at POLI BANK

Health Technology

Consumer Services

Transportation

Profile

Tomasz Franciszek Baran is currently the Vice Chairman-Management Board at Polski Bank Komorek Macierzystych SA since 2020.
He is also the Director at Stemlab sa and the Chief Commercial Officer at Vita 34 AG since 2022.
Previously, he served as the Chief Executive Officer at Famicordtx SA. He also held positions at Pliva Krakow Sa as Manager-Regional Sales & Product from 1998 to 2004, Astrazeneca Pharma Poland SP zoo as Manager-Marketing & Group Manager-Product from 2004 to 2008, and Stiefel Polska SP zoo as Marketing Manager from 2008 to 2009.
He has also worked as a Marketing Manager at GlaxoSmithKline Pharmaceuticals SA. Mr. Franciszek Baran holds an MBA from the University of Quebec and the Warsaw School of Economics.
He completed his undergraduate degree at the Medical University of Lublin in 1997.

Tomasz Franciszek Baran active positions

Companies	Position	Start
POLI BANK	Corporate Officer/Principal	31/12/2011
VITA 34 AG	Sales & Marketing	21/03/2022
Stemlab sa Stemlab sa BiotechnologyHealth Technology Stemlab SA provides umbilical cord stem cell isolation and cryopreservation. It processes and stores umbilical cord blood and tissue for therapeutic applications. The company was founded by André Rodrigues de Abreu Gomes, Raúl Morais dos Santos, Luís Gomes, Gonçalo Castelo-Branco, Daniel Taborda, and Alexandra Mendes in July 2003 and is headquartered in Cantanhede, Portugal.	Director/Board Member	-

All active positions of Tomasz Franciszek Baran

Former positions of Tomasz Franciszek Baran

Companies	Position	End
Stiefel Polska SP zoo	Corporate Officer/Principal	31/12/2008
Astrazeneca Pharma Poland SP zoo	Sales & Marketing	31/12/2007
Pliva Krakow Sa Pliva Krakow Sa Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Pliva Krakow Sa is a Polish pharmaceutical manufacturing company. The private company is based in Krakow, Poland.	Sales & Marketing	31/12/2003
Famicordtx SA	Chief Executive Officer	-
Glaxosmithkline Pharmaceuticals SA Glaxosmithkline Pharmaceuticals SA Pharmaceuticals: GenericHealth Technology Part of GSK Plc, GlaxoSmithKline Pharmaceuticals SA is a Polish company that manufactures drugs and vaccines. The private company is based in Poznan, Poland.	Sales & Marketing	-

See the detail of Tomasz Franciszek Baran's experience

Training of Tomasz Franciszek Baran

University of Quebec	Masters Business Admin
Warsaw School of Economics	Masters Business Admin
Medical University of Lublin	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tomasz Franciszek Baran's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
VITA 34 AG	Health Technology

Private companies	7
Pliva Krakow Sa Pliva Krakow Sa Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Pliva Krakow Sa is a Polish pharmaceutical manufacturing company. The private company is based in Krakow, Poland.	Health Technology
Stemlab sa Stemlab sa BiotechnologyHealth Technology Stemlab SA provides umbilical cord stem cell isolation and cryopreservation. It processes and stores umbilical cord blood and tissue for therapeutic applications. The company was founded by André Rodrigues de Abreu Gomes, Raúl Morais dos Santos, Luís Gomes, Gonçalo Castelo-Branco, Daniel Taborda, and Alexandra Mendes in July 2003 and is headquartered in Cantanhede, Portugal.	Health Technology
Polski Bank Komorek Macierzystych SA Polski Bank Komorek Macierzystych SA Other TransportationTransportation Polski Bank Komorek Macierzystych SA engages in the provision of stem cell collection services. The firm also offers stem cells transplantation. It operates through the following segments: B2C Afterbirth Tissue Banking Services (B2C), B2B Afterbirth Tissue Banking Services (B2B), and R&D Activities. The B2C segment refers to the services consisting in the preparation and storage of human biological material for individual retail customers. The B2B segment pertains to the services consisting in the preparation and/or storage of biological materials for business partners. The R&D Activities segment comprises of the group's research and development activities. The company was founded in 2002 and is headquartered in Warsaw, Poland.	Transportation
Astrazeneca Pharma Poland SP zoo
Stiefel Polska SP zoo
Famicordtx SA
Glaxosmithkline Pharmaceuticals SA Glaxosmithkline Pharmaceuticals SA Pharmaceuticals: GenericHealth Technology Part of GSK Plc, GlaxoSmithKline Pharmaceuticals SA is a Polish company that manufactures drugs and vaccines. The private company is based in Poznan, Poland.	Health Technology

See company connections